Carolyn Helene Baloh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Deficiency Syndromes | 2 | 2024 | 549 | 0.890 |
Why?
|
Peanut Hypersensitivity | 2 | 2022 | 219 | 0.830 |
Why?
|
Whooping Cough | 1 | 2023 | 86 | 0.820 |
Why?
|
Immune System Diseases | 1 | 2023 | 253 | 0.710 |
Why?
|
Hypersensitivity, Immediate | 1 | 2023 | 349 | 0.670 |
Why?
|
Agammaglobulinemia | 1 | 2021 | 174 | 0.670 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 235 | 0.620 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2021 | 648 | 0.610 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 100 | 0.610 |
Why?
|
Food Hypersensitivity | 1 | 2023 | 733 | 0.480 |
Why?
|
Enzyme Replacement Therapy | 2 | 2021 | 80 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5713 | 0.260 |
Why?
|
Disease Susceptibility | 2 | 2024 | 1794 | 0.250 |
Why?
|
Oncostatin M | 1 | 2024 | 42 | 0.230 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2024 | 57 | 0.220 |
Why?
|
Tetanus Toxoid | 1 | 2023 | 189 | 0.210 |
Why?
|
alpha-Glucosidases | 1 | 2020 | 46 | 0.180 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2024 | 204 | 0.180 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2020 | 43 | 0.170 |
Why?
|
Mast Cells | 2 | 2024 | 1407 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 252 | 0.160 |
Why?
|
Lymphocyte Count | 1 | 2021 | 793 | 0.160 |
Why?
|
Cryopreservation | 1 | 2023 | 733 | 0.150 |
Why?
|
Allergens | 2 | 2022 | 1441 | 0.150 |
Why?
|
Nasal Polyps | 1 | 2023 | 409 | 0.150 |
Why?
|
Autoimmunity | 1 | 2024 | 1360 | 0.130 |
Why?
|
Comorbidity | 2 | 2023 | 10588 | 0.130 |
Why?
|
Fetal Blood | 1 | 2023 | 1361 | 0.130 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 669 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 469 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4570 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 2021 | 945 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2024 | 3230 | 0.110 |
Why?
|
Methotrexate | 1 | 2020 | 1722 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1376 | 0.110 |
Why?
|
Infant | 4 | 2023 | 36510 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2276 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2257 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3345 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2020 | 2324 | 0.090 |
Why?
|
Humans | 14 | 2024 | 768393 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3827 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6541 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2917 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4785 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4209 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9682 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14784 | 0.070 |
Why?
|
Infant, Newborn | 1 | 2023 | 26411 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26375 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.050 |
Why?
|
Nasal Mucosa | 1 | 2024 | 411 | 0.050 |
Why?
|
Signal Transduction | 1 | 2024 | 23631 | 0.050 |
Why?
|
Pregnancy | 1 | 2022 | 30200 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 30022 | 0.040 |
Why?
|
Female | 6 | 2024 | 397089 | 0.040 |
Why?
|
Desensitization, Immunologic | 1 | 2022 | 559 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2038 | 0.030 |
Why?
|
Risk Factors | 1 | 2023 | 74962 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1327 | 0.030 |
Why?
|
Child | 2 | 2020 | 80891 | 0.030 |
Why?
|
Administration, Oral | 1 | 2022 | 4039 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4177 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 60049 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2425 | 0.020 |
Why?
|
Adult | 3 | 2024 | 223640 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2533 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2023 | 3695 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3785 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 89184 | 0.020 |
Why?
|
Male | 4 | 2024 | 364902 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6318 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5796 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42650 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 19022 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10478 | 0.020 |
Why?
|
Time Factors | 1 | 2020 | 40272 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65379 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81801 | 0.010 |
Why?
|
Aged | 1 | 2024 | 171562 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223491 | 0.010 |
Why?
|